Revenue for the quarter was $274.9 million, down from $279.5 million during the year-ago quarter and below the analyst forecast of $291.6 million.
The company said it is maintaining its 2019 earnings guidance with a consolidated range of $2.83 to $3.03 per diluted share.
Price: 47.36, Change: -0.13, Percent Change: -0.27
|FDA Advisory Committee Votes Unanimously to Back Hor...|
|Insider Trends: Insider at Zymeworks Exercises Optio...|
|US TREASURIES: Monday Event Agenda|
|Alibaba's Ant Financial, Vanguard Partner in Wealth ...|
|Insider Trends: Insider Sales Continue 90-Day Trend ...|